Form 4 for BSX Boston Scientific
Accepted 2023-08-30 00:00:00 ET · period of report 2023-08-28 · accession 0001225208-23-008555 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-08-30 | 2023-08-28+ | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $53.48 | -18.6K | 65.2K | -22% | -$996.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-29 | S | D | 4,657 | $54.50 | 60,588 | D | — | — | (F3) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $54.50 to $54.51, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-08-28 | S | D | 13,971 | $53.14 | 65,245 | D | — | — | (F2) Includes shares acquired on June 30, 2023 under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available. |